VITAMIN/MINERAL
Niacin (B3) N1
N1 -methylnicotinamide -methyl-2-pyridone-5-carboxamide (2-pyridone)
Pyridoxine (B6) Pyridoxal 5’-phosphate (PLP)
4-Pyridoxic acid (PA)
Erythrocyte aspartate aminotransferase (eAST) index & Erythrocyte alanine aminotransferase (eALT) index
Folate (B9) Folate
Plasma or RBC
24-hour urine Whole blood
39-98 nmol/L
> 3 μmol/d <1.6 <1.25
RBC erythrocyte Serum or plasma
Cobalamin (B12) Vitamin B12
Methylmalonic acid (MMA) Homocysteine (Hcy)
Serum or plasma Serum
Serum or plasma 170-250 pg/mL
0.08-0.56 μmol/L
5-15 μmol/L 65 y: <20 μmol/L
Adult: 140-628 ng/mL Pediatric: >160 ng/mL
<20 nmol/L <3 μmol/d
PLP indicates recent intake; need to fast 8-12 hours for more accurate level.
If low albumin, altered alkaline phosphatase, or critically ill intestinal transplant patient, RBC PLP more reliable than plasma PLP.
A combination of the 3 tests is recommended. Diagnosis of toxicity is clinical.
<140 ng/mL <3 ng/mL
<150 pg/mL Elevated
Elevated
Some sources suggest <300-350 pg/mL indicates deficiency.
Megaloblastic anemia = mean corpuscular volume (MCV) >100 fL/cell; even if no ane- mia, folate can mask vitamin B12 deficiency.
MMA and hcy greater than normal support vitamin B12 deficiency.
Note: Hcy may increase in folate deficiency; MMA may increase with renal failure or intravascular volume depletion.
LABORATORY ASSAYS FOR VITAMIN AND MINERAL STATUS PEDIATRIC MALNUTRITION INDICATORS 58
Plasma homocysteine level of ≥15 μmol/L can indicate folate and/or vitamin B12 deficiency.
Normal methylmalonic acid level in folate deficiency
LABORATORY METHOD NORMAL
24-hour urine 24-hour urine
17.5-46.7 μmol/day
INTERPRETATION DEFICIENCY TOXICITY
<5.8 μmol/day <2 mg/g Cr
Diagnosis of deficiency is usually clinical.
COMMENTS
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70